Ella Jeffries / beckershospitalreview - A second scan using prostate-specific membrane antigen positron emission tomography changed treatment plans for nearly half of patients with recurrent prostate cancer whose initial scan was negative, according to research published in the July issue of Th…
AI Summary: Follow-up prostate-specific membrane antigen (PSMA) PET imaging uncovered disease missed on initial scans and altered management in nearly half of patients. Repeat imaging revealed occult or more extensive disease, prompting switches from surveillance to definitive or systemic therapies and adjustments to radiation plans. The data argue for selective reimaging when staging is uncertain.
oncodaily - Breast cancer incidence is increasing rapidly among Asian American, Native Hawaiian, and Pacific Islander women in the United States, with especially concerning trends in early-onset disease, distant-stage diagnosis, and aggressive […]
AI Summary: New research shows a rapid rise in breast cancer incidence among Asian American, Native Hawaiian and Pacific Islander women, highlighting shifting epidemiology and unmet screening needs. The findings call for tailored public health strategies, culturally competent outreach and earlier detection efforts to address an alarming trend in populations historically considered lower risk.
Katie Adams / medcitynews - A former Mayo Clinic research director claims she was silenced, demoted and ultimately fired for sounding the alarm on AI safety and patient privacy lapses at the health system. Traci Tamiko Eto is now suing Mayo for retaliation.The post Former Mayo Clini…
AI Summary: A former Mayo Clinic research director has filed suit alleging retaliation after raising concerns about the health system’s use and oversight of clinical AI. The complaint accuses leadership of suppressing warnings, sidelining the whistleblower and covering up problematic practices — seeking damages and reforms while triggering closer scrutiny of institutional AI governance.
Emily Olsen / healthcaredive - Venture capital funding deals worth $100 million or more made up nearly half of all money invested so far this year, according to Rock Health.
AI Summary: Venture activity in digital health experienced a marked uptick in H1 as a handful of large funding rounds and increased AI investment lifted total deal values, reshaping fundraising norms. Investors are writing bigger checks, startups are recalibrating growth plans, and the sector’s fundraising dynamics appear to be entering a more concentrated, high‑stakes phase.
Madeline Scheetz / beckershospitalreview - Nashville, Tenn.-based HCA Healthcare estimates changes to the ACA environment will cost it from $1 billion to $1.2 billion in 2026, up significantly from an April estimate of $600 million to $900 million, according to July 14 preliminary financial result…
AI Summary: HCA Healthcare warned investors that exchange and ACA market dynamics will reduce insured membership and revenue, prompting downward revisions to 2026 guidance and an anticipated multi‑hundred‑million to $1.2B impact. The company cited coverage losses and enrollment disruption as the core drivers behind its reduced financial forecast.


StackHealth RSS
StackHealth Time Machine
More StackHealth
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.